Water → Convergence
반응식
[F:1][C:2]([F:19])([F:18])[C:3]1[CH:8]=[CH:7][C:6]([S:9]([N:12]2[CH2:17][CH2:16][NH:15][CH2:14][CH2:13]2)(=[O:11])=[O:10])=[CH:5][CH:4]=1.[N:20]1[N:24]2[CH:25]=[CH:26][CH:27]=[N:28][C:23]2=[C:22]([C:29](O)=[O:30])[CH:21]=1.C1C=CC2N(O)N=NC=2C=1.O.CN(C(ON1N=NC2C=CC=CC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F.CCN(C(C)C)C(C)C>CN(C=O)C>[F:19][C:2]([F:1])([F:18])[C:3]1[CH:4]=[CH:5][C:6]([S:9]([N:12]2[CH2:17][CH2:16][N:15]([C:29]([C:22]3[CH:21]=[N:20][N:24]4[CH:25]=[CH:26][CH:27]=[N:28][C:23]=34)=[O:30])[CH2:14][CH2:13]2)(=[O:10])=[O:11])=[CH:7][CH:8]=1참가 물질
8
반응물 6
생성물 1
시약·촉매·용매 1
실험 절차
To a solution of 1-{[4-(trifluoromethyl)phenyl]sulfonyl}piperazine (may be prepared as described in Description 1) (200 mg, 0.680 mmol) in DMF (5 ml) was added pyrazolo[1,5-a]pyrimidine-3-carboxylic acid (111 mg, 0.680 mmol), HOBT.H2O (104 mg, 0.680 mmol) and HBTU (258 mg, 0.680 mmol). Finally DIPEA (0.356 ml, 2.039 mmol) was added and the reaction mixture was stirred at rt for 20 hours. Solvent was removed by evaporation, the crude partitioned between DCM (50 ml) and saturated aq. sodium bicarbonate (50 ml), the DCM layer collected, dried (hydrophobic frit) and evaporated. MDAP purification yielded the title compound (317 mg) as an off-white solid.
후처리
- customSolvent was removed by evaporation
- customthe crude partitioned between DCM (50 ml) and saturated aq. sodium bicarbonate (50 ml)
- customthe DCM layer collected
- customdried (hydrophobic frit)
- customevaporated
- customMDAP purification
출처 및 근거
- ORD 기록
- ord-48aa982af32e44d6ad25a834957fe306
- 출처 데이터셋
- uspto-grants-2012_01
- 특허 번호
- US08093249B2
반응 노트
불러오는 중…